Showing 13,701 - 13,720 results of 104,179 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 5 ((wt decrease) OR (a decrease)) ))', query time: 1.83s Refine Results
  1. 13701
  2. 13702
  3. 13703
  4. 13704

    Adduct Formation between Alkali Metal Ions and Anionic LV<sup>V</sup>O<sub>2</sub><sup>-</sup> (L<sup>2-</sup> = Tridentate ONS Ligands) Species:  Syntheses, Structural Investigati... by Satyabrata Samanta (2305432)

    Published 2003
    “…The putative product is a mixed-oxidation (μ-oxo)divanadium(IV/V) species as revealed from EPR, electronic spectroscopy, dynamic <sup>1</sup>H NMR, and redox studies.…”
  5. 13705
  6. 13706
  7. 13707
  8. 13708

    The penetration of OU14 but not RACE1 decreased in epidermal cells in which <i>MLO</i> expression was suppressed by transient induced gene silencing (TIGS). by Takashi Yaeno (11320498)

    Published 2021
    “…Error bars represent standard deviation (n = 5). The empty pANDA-mini vector was introduced as a negative control. …”
  9. 13709
  10. 13710
  11. 13711
  12. 13712

    Decreased total β-cell mass in RIP-Cre Dicer1<i><sup>Δ/Δ</sup></i> visualised by optical projection tomography. by Martins Kalis (190382)

    Published 2011
    “…<p>A. Optical tomographic sections based on insulin-labeling of adult pancreas of 5, 8 and 12 weeks old RIP-Cre <i>Dicer1</i> and control littermate mice. …”
  13. 13713
  14. 13714
  15. 13715
  16. 13716
  17. 13717
  18. 13718

    The expression of PrP<sup>C</sup> on mouse bone marrow (BM) and spleen erythroid precursors is upregulated in early erythroblasts and, then, decreases with the cells' maturation. by Martin Panigaj (345008)

    Published 2013
    “…Expression of PrP<sup>C</sup> on early basophilic erythroblasts (EryA) is significantly higher (p>0.005, n = 5) in comparison with proerythroblasts (ProE), both in BM (upper) and spleen (lower). …”
  19. 13719
  20. 13720

    Table_5_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx by Monica Franzese (8983097)

    Published 2022
    “…The cohorts were monitored from the 12th day after the first vaccine dose up to 1 month after the third vaccine dose for a total of eight time points and about 1 year of surveillance (T1 = 12 days after the first dose; T2 = 10 days after the second dose; T3 = 1 month after the second dose; T4 = 3 months after the second dose; T5 = 4 months after the second dose; T6 = 5 months after the second dose; T7 = 7 months after the second dose; T8 = 1 month after the third dose for Group 1; T8* = 9 months after the second dose for Group 2; T9 = 1 month after the third dose for Group 2). …”